Neonatal lupus erythematosus - Cardiac manifestations and atrio-ventricular conduction block

Harefuah

Volumn 146, Issue 12, 2007, Pages 940-944

  Nussinovitch, Udi ^a   Shoenfeld, Yehuda ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Atrio ventricular conduction block; Cardiomyopathy; Congestive heart failure; Neonatal lupus erythematosus; Systemic Lupus Erythematosus (SLE)

Indexed keywords

AUTOANTIBODY;

ARTICLE; ATRIOVENTRICULAR BLOCK; BLOOD; HEART DISEASE; HUMAN; IMMUNOLOGY; ISRAEL; NEWBORN; NEWBORN DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ATRIOVENTRICULAR BLOCK; AUTOANTIBODIES; HEART DISEASES; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; ISRAEL; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 41449103030     PISSN: 00177768     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Buyon JP, Hiebert R, Copel J & al, Autoimmune-associated congenital heart block: demographics, mortality, morbidity and recurrence rates obtained from a national neonatal lupus registry. J Am Coll Cardiol, 1998. 31: 1658-66.
2. Dhar JP & Sokol RJ, Lupus and pregnancy: complex yet manageable. Clin Med Res, 2006; 4: 310-21.
3. D'Cruz DP, Khamashta MA & Hughes GR, Systemic lupus erythematosus. Lancet, 2007; 369: 587-96.
4. Meyer O, Making pregnancy safer for patients with lupus. Joint Bone Spine, 2004; 71: 178-82.
5. Sherer Y, Gorstein A, Fritzler MJ & Shoenfeld Y, Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum, 2004; 34: 501-37.
6. Molad Y, Systemic lupus erythematosus and pregnancy. Curr Opin Obstet Gynecol, 2006; 18: 613-7.
7. Xue D, Shi H, Smith JD & al, A lupus-like syndrome develops in mice lacking the Ro 60-kDa protein, a major lupus autoantigen. Proc Natl Acad Sci USA, 2003; 100: 7503-8.
8. Clancy RM & Buyon JP, Autoimmune-associated congenital heart block: dissecting the cascade from immunologic insult to relentless fibrosis. Anat Rec A Discov Mol Cell Evol Biol, 2004; 280: 1027-35.
9. Boh EE, Neonatal lupus erythematosus. Clin Dermatol, 2004; 22: 125-8.
10. Buyon JP & Clancy RM, Neonatal lupus syndromes. Curr Opin Rheumatol, 2003; 15: 535-41.
11. Lee LA, Neonatal lupus: clinical features and management. Paediatr Drugs, 2004; 6: 71-8.
12. Meng C & Lockshin M, Pregnancy in lupus. Curr Opin Rheumatol, 1999; 11: 348-51.
13. Lee LA, Transient autoimmunity related to maternal autoantibodies: neonatal lupus. Autoimmun Rev, 2005; 4. 207-13.
14. Buyon JP, Rupel A & Clancy RM, Neonatal lupus syndromes. Lupus, 2004; 13: 705-12.
15. Lockshin MD & Sammaritano LR, Lupus pregnancy. Autoimmunity, 2003; 36: 33-40.
16. Salomonsson S, Dorner T, Theander E & al, A serologic marker for fetal risk of congenital heart block. Arthritis Rheum, 2002; 46: 1233-41.
17. Costedoat-Chalumeau N, Amoura Z, Villain E & al, Anti-SSA/Ro antibodies and the heart: more than complete congenital heart block? A review of electrocardiographic and myocardial abnormalities and of treatment options. Arthritis Res Ther, 2005; 7: 69-73.
18. Brucato A, Frassi M, Franceschini F & al, Risk of congenital complete heart block in newborns of mothers with anti-Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum, 2001; 44: 1832-5.
19. Lazzerini PE, Acampa M, Guideri F & al, Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA-positive connective tissue diseases. Arthritis Rheum, 2004; 50: 1248-52.
20. Brucato A, Doria A, Frassi M & al, Pregnancy outcome in 100 women with autoimmune diseases and anti-Ro/SSA antibodies: a prospective controlled study. Lupus, 2002; 11: 716-21.
21. Tran HB, Macardle PJ, Hiscock J & al, Anti-La/SSB antibodies transported across the placenta bind apoptotic cells in fetal organs targeted in neonatal lupus. Arthritis Rheum, 2002; 46: 1572-9.
22. Miranda-Carus ME, Boutjdir M, Tseng CE & al, Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model. J Immunol, 1998; 161: 5886-92.
23. Boutjdir M, Chen L, Zhang ZH & al, Arrhythmogenicity of IgG and anti-52-kD SSA/Ro affinity-purified antibodies from mothers of children with congenital heart block. Circ Res, 1997; 80: 354-62.
24. Miranda-Carus ME, Askanase AD, Clancy RM & al, AntiÙSSA/Ro and anti-SSB/La autoantibodies bind the surface of apoptotic fetal cardiocytes and promote secretion of TNF-alpha by macrophages. J Immunol, 2000; 165: 5345-51.
25. Viana VS, Garcia S, Nascimento JH & al, Induction of in vitro heart block is not restricted to affinity purified anti-52 kDa Ro/SSA antibody from mothers of children with neonatal lupus. Lupus, 1998; 7: 141-7.
26. Garcia S, Nascimento JH, Bonfa E & al, Cellular mechanism of the conduction abnormalities induced by serum from anti-Ro/SSA-positive patients in rabbit hearts. J Clin Invest, 1994; 93: 718-24.
27. Kalush F, Rimon E & Mozes E, Neonatal lupus erythematosus in offspring of mothers with experimental systemic lupus erythematosus. Am J Reprod Immunol, 1992; 28: 264-8.
28. Breur JM, Visser GH, Kruize AA & al, Treatment of fetal heart block with maternal steroid therapy: case report and review of the literature. Ultrasound Obstet Gynecol, 2004; 24: 467-72.
29. Jayaprasad N, Johnson F & Venugopal K, Congenital complete heart block and maternal connective tissue disease. Int J Cardiol, 2006. 112: 153-8.
30. Kaaja R & Julkunen H, Prevention of recurrence of congenital heart block with intravenous immunoglobulin and corticosteroid therapy: comment on the editorial by Buyon & al. Arthritis Rheum, 2003; 48: 280-1.